Day: September 14, 2024

CHICAGO -- Hormone therapy for menopause symptoms reduced insulin resistance in healthy postmenopausal women, a systematic review and meta-analysis of ...

The 24-hour news cycle is just as important to medicine as it is to politics, finance, or sports. At MedPage ...

BARCELONA — The combination of standard FOLFOX chemotherapy with doublet immunotherapy did not improve progression-free survival compared with chemotherapy alone in ...

Adding preoperative chemoradiotherapy to perioperative chemotherapy failed to boost survival, versus perioperative chemotherapy alone, in resectable gastric and gastroesophageal junction ...

Trastuzumab deruxtecan (Enhertu, T-DXd) therapy produced "substantial and durable" overall and intracranial clinical activity in patients with HER2-positive advanced breast ...

Adjuvant durvalumab (Imfinzi) provided no significant improvement in disease-free survival compared with placebo following resection in patients with early-stage non-small ...

TTHealthWatch is a weekly podcast from Texas Tech. In it, Elizabeth Tracey, director of electronic media for Johns Hopkins Medicine ...

Lowe Taylor is a physiatrist. In 2018, I was a young medical resident working on a spinal cord injury unit ...

BARCELONA – Adding preoperative chemoradiation to standard-of-care perioperative chemotherapy did not improve overall or progression-free survival in patients with resectable ...

The US Food and Drug Administration (FDA) has approved the targeted interleukin (IL)-13 inhibitor lebrikizumab (Ebglyss) for the treatment of ...

The NHS is urging parents and carers of two and three-year-olds to schedule a flu vaccine for their children ahead ...